Blue Green wins Ashdod sewage tender

The sewage treatment facility will process 35,000 cubic meters (35 million liters) of waste water daily.

By DANIEL KENNEMER
January 30, 2006 07:25

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Blue Green Development & Investments, a subsidiary of Housing & Construction Holding Co. (Shikun u-Binui) won a NIS 36-million tender to treat Ashdod's waste water for six years, with an option to extend the contract for six more years, the company said Sunday. The sewage treatment facility will process 35,000 cubic meters (35 million liters) of waste water daily. Blue Green is second only to Mekorot in handling waste water in Israel, the company said. Two-thirds of Israel's sewage is treated and reused for agricultural irrigation, the highest proportion worldwide, the company said. Spain trails behind in second place, recycling only 13% of its waste water.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS